After COVID-19, Could This Be the Next Billion-Dollar Vaccine Market?
For vaccine leaders Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE), the coronavirus vaccine market represents more than $50 billion this year. Moderna expects $20 billion in vaccine sales. And Pfizer and its partner BioNTech (NASDAQ: BNTX) will split profits after taking in $33.5 billion in vaccine revenue.
Those numbers sound tough to beat. But the companies don't necessarily have to top this performance. Instead, they may just use their expertise to enter a smaller market -- but one that still could offer sales in the billions. So, what's the next focus for Moderna, Pfizer, and rivals? Let's find out.
Image source: Getty Images.
Source Fool.com
